XGEN.DE vs. XMME.DE
XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) and XMME.DE (Xtrackers MSCI Emerging Markets UCITS ETF 1C) are both exchange-traded funds - XGEN.DE is a Health & Biotech Equities fund tracking the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100, while XMME.DE is a Emerging Markets Equities fund tracking the MSCI Emerging Markets. Both are passively managed. Over the past 3 years, XGEN.DE returned 1.39%/yr vs 21.36%/yr for XMME.DE. At a 0.44 correlation, their price movements are largely independent. XGEN.DE charges 0.30%/yr vs 0.18%/yr for XMME.DE.
Performance
XGEN.DE vs. XMME.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XGEN.DE achieves a -1.40% return, which is significantly lower than XMME.DE's 30.06% return.
XGEN.DE
- 1D
- 3.92%
- 1M
- 5.33%
- YTD
- -1.40%
- 6M
- -3.45%
- 1Y
- 22.88%
- 3Y*
- 1.39%
- 5Y*
- —
- 10Y*
- —
XMME.DE
- 1D
- -1.04%
- 1M
- 5.19%
- YTD
- 30.06%
- 6M
- 29.85%
- 1Y
- 50.91%
- 3Y*
- 21.36%
- 5Y*
- 8.66%
- 10Y*
- —
XGEN.DE vs. XMME.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -1.40% | 7.38% | 2.95% | -5.84% | -9.98% |
XMME.DE Xtrackers MSCI Emerging Markets UCITS ETF 1C | 30.06% | 18.69% | 13.82% | 5.89% | -6.02% |
Correlation
The correlation between XGEN.DE and XMME.DE is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.39 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.44 |
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022 | 0.44 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XGEN.DE vs. XMME.DE — Risk / Return Rank
XGEN.DE
XMME.DE
XGEN.DE vs. XMME.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) and Xtrackers MSCI Emerging Markets UCITS ETF 1C (XMME.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XGEN.DE | XMME.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.78 | ||
| Sortino ratioReturn per unit of downside risk | -2.11 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.55 | -0.34 |
| Calmar ratioReturn relative to maximum drawdown | 1.49 | 4.98 | -3.49 |
| Martin ratioReturn relative to average drawdown | 3.61 | 18.04 | -14.43 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XGEN.DE | XMME.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.23 | 3.00 | -1.78 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.51 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.11 | 0.45 | -0.55 |
Drawdowns
XGEN.DE vs. XMME.DE - Drawdown Comparison
The maximum XGEN.DE drawdown since its inception was -37.58%, which is greater than XMME.DE's maximum drawdown of -31.96%. Use the drawdown chart below to compare losses from any high point for XGEN.DE and XMME.DE.
Loading charts...
Drawdown Indicators
| XGEN.DE | XMME.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.58% | -31.96% | -5.62% |
Max Drawdown (1Y)Largest decline over 1 year | -14.99% | -10.67% | -4.32% |
Max Drawdown (3Y)Largest decline over 3 years | -28.21% | -19.16% | -9.05% |
Max Drawdown (5Y)Largest decline over 5 years | — | -24.38% | — |
Current DrawdownCurrent decline from peak | -14.86% | -1.04% | -13.82% |
Average DrawdownAverage peak-to-trough decline | -19.44% | -9.53% | -9.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.19% | 2.95% | +3.24% |
Volatility
XGEN.DE vs. XMME.DE - Volatility Comparison
The current volatility for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) is 6.48%, while Xtrackers MSCI Emerging Markets UCITS ETF 1C (XMME.DE) has a volatility of 7.48%. This indicates that XGEN.DE experiences smaller price fluctuations and is considered to be less risky than XMME.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XGEN.DE | XMME.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.48% | 7.48% | -1.00% |
Volatility (6M)Calculated over the trailing 6-month period | 13.73% | 14.90% | -1.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.19% | 17.70% | +0.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.66% | 16.74% | +1.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.66% | 18.61% | +0.05% |
XGEN.DE vs. XMME.DE - Expense Ratio Comparison
XGEN.DE has a 0.30% expense ratio, which is higher than XMME.DE's 0.18% expense ratio.
Dividends
XGEN.DE vs. XMME.DE - Dividend Comparison
Neither XGEN.DE nor XMME.DE has paid dividends to shareholders.
Frequently Asked Questions
XGEN.DE and XMME.DE have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XMME.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XMME.DE is cheaper with a 0.18% expense ratio, compared with 0.30% for XGEN.DE.
XGEN.DE is categorized as Health & Biotech Equities, while XMME.DE is Emerging Markets Equities. XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100, while XMME.DE tracks MSCI Emerging Markets. Their fees differ too: 0.30% for XGEN.DE and 0.18% for XMME.DE.
Find the right allocation for XGEN.DE and XMME.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer